Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 237

Sort by

Sort Order Select

Journal Articles

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention

Andrew B Wilks, MD MS, Daniel Douce, MD, Steven Ades, MD, Mary Cushman, MD MSc, Neil A. Zakai, MD MSc, Chris E. Holmes, MD PhD

Blood (2019) 134 (Supplement_1): 709.

https://doi.org/10.1182/blood-2019-128831

Published: 2019

Journal Articles

Rare Germline Mutations in Complement Regulatory Genes Make the Antiphospholipid Syndrome Catastrophic

Shruti Chaturvedi, MBBS, MS, Evan M Braunstein, MD PhD, Xuan Yuan, MD MSc, Hang Chen, Ravi Kumar Alluri, PhD, Michael B. Streiff, MD, Michelle Petri, MD MPH, Mark Crowther, MD MSc, FRCPC, Keith R McCrae, MD, Robert A. Brodsky, MD

Blood (2019) 134 (Supplement_1): 4.

https://doi.org/10.1182/blood-2019-129115

Published: 2019

Journal Articles

Thrombocytopenia and Anticoagulation: Impact of the ISTH SCC Anticoagulation Guidelines in Patients with Thrombocytopenia

Nicole Held, DO, Lisa Baumann Kreuziger, MD MS, Benjamin Jung

Blood (2019) 134 (Supplement_1): 2098.

https://doi.org/10.1182/blood-2019-127596

Published: 2019

Journal Articles

Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living Therapeutics TM Products

Guillaume Carmona, PhD, Lauren Barney, PhD, Jared Sewell, PhD, Ryan Newman, Christine Carroll, Michael Beauregard, Janet Huang, MSc, Richard W Heidebrecht, Jr., PhD, Deya Corzo, MD, David Moller, MD, Devyn Smith, PhD, David Peritt, PhD, Rogerio Vivaldi, MD MBA

Blood (2019) 134 (Supplement_1): 2065.

https://doi.org/10.1182/blood-2019-127050

Published: 2019

Journal Articles

Prophylactic Treatment in People with Severe Hemophilia B in the US: An Analysis of Real-World Healthcare System Costs and Clinical Outcomes

Declan Noone, MSc, Gabriel Pedra, PhD, Sohaib Asghar, MSc, Jamie O'Hara, MSc, Eileen K Sawyer, PhD, Nanxin (Nick) Li, PhD

Blood (2019) 134 (Supplement_1): 2118.

https://doi.org/10.1182/blood-2019-126576

Published: 2019

Journal Articles

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Christine G. Kohn, PharmD, Gary H. Lyman, MD MPH, Nicole M. Kuderer, Thomas J. Bunz, PharmD, PhD, Craig I. Coleman, PharmD

Blood (2019) 134 (Supplement_1): 3673.

https://doi.org/10.1182/blood-2019-128581

Published: 2019

Journal Articles

Concurrent Treatment of VEGFR Tyrosine Kinase Inhibitors (TKIs) and Factor Xa Inhibitors Is Associated with Increased Bleeding Risks

Sandip Patel, MBBS, Tiffany George, MD, Tzu-Fei Wang, MD MPH, Sherry Mori Vogt, Pharm D, Edmund Folefac, MD, Ming Yin, MD

Blood (2019) 134 (Supplement_1): 3681.

https://doi.org/10.1182/blood-2019-130465

Published: 2019

Journal Articles

Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies

Alex C. Spyropoulos, MD, Concetta Lipardi, MD PhD, Alexander T Cohen, MBBS, MSc, MD, Biljana Vučković, MD PhD, Jianfeng Xu, PhD, Wentao Lu, PhD, Theodore E. Spiro, MD, Elliot S. Barnathan, MD, Gary E. Raskob, PhD

Blood (2019) 134 (Supplement_1): 3671.

https://doi.org/10.1182/blood-2019-122945

Published: 2019

Journal Articles

Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation

Pável E Olivera, MD, César A Velasquez, MD, Desirée Campoy, MD, Gonzalo Artaza, MD, Tania Canals, MD, Katia Flores, MD, Silvia Ruiz, MD, Alessandra Comai, MD, Erik A Johansson, MD, Gabriela S Ene, MD PhD, Gabriela Bastidas, MD, Maricel Subira, MD PhD, Jorge Sierra, MD, Ramón Salinas, MD PhD

Blood (2019) 134 (Supplement_1): 3661.

https://doi.org/10.1182/blood-2019-128300

Published: 2019

Journal Articles

Cerebral Venous Thrombosis Case Series at a Tertiary Care Hospital: Exploring Treatment Safety and Efficacy of Direct Oral Anticoagulants

Mohammed Abdullah Alsheef, MD, Mukhtar Alomar, PharmD, Abdul Rehman Z. Zaidi, MBBS, Ghaydaa Juma Kullab, MD, Mohammed AlHazzaa, MD, Asaad Bafaraj, MD, Abdullah Badahman, MD

Blood (2019) 134 (Supplement_1): 3658.

https://doi.org/10.1182/blood-2019-128406

Published: 2019

Journal Articles

Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of Anticoagulation

Shyam K Poudel, Chandana A Reddy, MS, Deborah Y Park, BS, Mailey L Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS, Jung-Min Song, RN,CNS, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2019) 134 (Supplement_1): 3458.

https://doi.org/10.1182/blood-2019-127581

Published: 2019

Journal Articles

Safety of Doacs in Patients with CNS Malignancies

Andrew Swartz, MD, Jan Drappatz

Blood (2019) 134 (Supplement_1): 1160.

https://doi.org/10.1182/blood-2019-125161

Published: 2019

Journal Articles

Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study

Robert F. Sidonio, Jr., MD MSc, Angela C. Weyand, MD, Dunlei Cheng, PhD, Crystal Watson

Blood (2019) 134 (Supplement_1): 1132.

https://doi.org/10.1182/blood-2019-128318

Published: 2019

Journal Articles

VWF and FVIII Levels after Desmopressin Are Associated with the Bleeding Phenotype in Type 1 VWD

Ferdows Atiq, Lisette M. Schütte, MD, Agnes E.M. Looijen, Bsc, Johan Boender, MD, Moniek P.M. de Maat, PhD, Marieke J.H.A. Kruip, MD PhD, Frank W.G. Leebeek, MD PhD

Blood (2019) 134 (Supplement_1): 1116.

https://doi.org/10.1182/blood-2019-123634

Published: 2019

Journal Articles

The Burden of Clinically Significant Bleeding, Thrombocytopenia and Platelet Transfusions in Myelodysplastic Syndromes

Kathleen Pao Lynn Cheok, MBBS, Rakchha Chhetri, MBBS, Li Yan A Wee, BSc (Hons), Arabelle Salvi, Bachelor of Pharmacy, Simon McRae, MD MBBS, MSc, David John Roxby, B App Sc, M App Sc, ARCPA, Deepak Singhal, MBBS, MD FRACP, FRCPA, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD

Blood (2019) 134 (Supplement_1): 719.

https://doi.org/10.1182/blood-2019-125273

Published: 2019

Journal Articles

Cost-Utility Analysis of Apixaban Compared to Usual Care for the Primary Thromboprophylaxis of Ambulatory Cancer Patients Initiating Chemotherapy

Miriam Kimpton, MD, Srishti Kumar, MSc, Philip S. Wells, MDMSc,FRCP, Marc Carrier, MD, Kednapa Thavorn, MPharm, PhD

Blood (2019) 134 (Supplement_1): 329.

https://doi.org/10.1182/blood-2019-127286

Published: 2019

Journal Articles

Prevalence, Clinical Characteristics and Outcome of Von Willebrand Disease in Oman

Shamsa Alkaabi, Aala Alzadjali, Mustafa Wasifuddin, Ibrahim Suliman Masoud Alghaithi, MD, Murtadha Al-Khabori, MD, Anil Pathare, MD PhD FCPS, MBBS, Yasser Wali, MD

Blood (2019) 134 (Supplement_1): 4939.

https://doi.org/10.1182/blood-2019-123915

Published: 2019

Journal Articles

Prothrombin Complex Concentrate in the Management of Major Bleeding Induced By Oral Anticoagulant Therapy: Experience of a Tertiary Care Center

Mohammed Abdullah Alsheef, MD, Abdul Rehman Z. Zaidi, MBBS, Ghaydaa Juma Kullab, MD

Blood (2019) 134 (Supplement_1): 4967.

https://doi.org/10.1182/blood-2019-126740

Published: 2019

Journal Articles

International Survey for Strategies Used for Oral Anticoagulation Reversal in Children

Shveta Gupta, MBBS, Ayesha Zia, MD, Ravindra Sarode, MD

Blood (2019) 134 (Supplement_1): 4976.

https://doi.org/10.1182/blood-2019-129118

Published: 2019

Journal Articles

Perioperative Bleeding Risk Assessment in a Cohort of Children with Low Levels of Von Willebrand Factor

Berardino Pollio, Maria Messina, Irene Ricca, Mauro Pagliarino, Ugo Ramenghi, MD, Antonio Coppola, Anna Castiglione, Giovannino Ciccone, Teresa Ceglie, Anna Mondino, Paolo Tavormina, Claudia Linari

Blood (2019) 134 (Supplement_1): 2400.

https://doi.org/10.1182/blood-2019-130023

Published: 2019

NARROW

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention

Rare Germline Mutations in Complement Regulatory Genes Make the Antiphospholipid Syndrome Catastrophic

Thrombocytopenia and Anticoagulation: Impact of the ISTH SCC Anticoagulation Guidelines in Patients with Thrombocytopenia

Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living Therapeutics TM Products

Prophylactic Treatment in People with Severe Hemophilia B in the US: An Analysis of Real-World Healthcare System Costs and Clinical Outcomes

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Concurrent Treatment of VEGFR Tyrosine Kinase Inhibitors (TKIs) and Factor Xa Inhibitors Is Associated with Increased Bleeding Risks

Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies

Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation

Cerebral Venous Thrombosis Case Series at a Tertiary Care Hospital: Exploring Treatment Safety and Efficacy of Direct Oral Anticoagulants

Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of Anticoagulation

Safety of Doacs in Patients with CNS Malignancies

Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study

VWF and FVIII Levels after Desmopressin Are Associated with the Bleeding Phenotype in Type 1 VWD

The Burden of Clinically Significant Bleeding, Thrombocytopenia and Platelet Transfusions in Myelodysplastic Syndromes

Cost-Utility Analysis of Apixaban Compared to Usual Care for the Primary Thromboprophylaxis of Ambulatory Cancer Patients Initiating Chemotherapy

Prevalence, Clinical Characteristics and Outcome of Von Willebrand Disease in Oman

Prothrombin Complex Concentrate in the Management of Major Bleeding Induced By Oral Anticoagulant Therapy: Experience of a Tertiary Care Center

International Survey for Strategies Used for Oral Anticoagulation Reversal in Children

Perioperative Bleeding Risk Assessment in a Cohort of Children with Low Levels of Von Willebrand Factor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only